Your session is about to expire
← Back to Search
Nasal Pump
Nasal Pump for Dry Eye Syndrome
Phase 4
Waitlist Available
Research Sponsored by Oyster Point Pharma, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 days
Awards & highlights
Study Summary
This trial aims to find out if the Tyrvaya nasal pump is safe to use.
Who is the study for?
This trial is for adults over 18 who have pink eye or dry eye syndrome and are willing to follow the study's procedures. They must consent to participate. People can't join if they're in another drug/device study or used an investigational drug/device within the last 30 days.Check my eligibility
What is being tested?
The safety of a nasal pump called Tyrvaya is being evaluated in this Phase 4 study. Participants will use Tyrvaya to see how safe it is for treating conditions like pink eye and various forms of dry eye syndrome.See study design
What are the potential side effects?
While specific side effects aren't listed, participants will be monitored for any adverse reactions related to using the Tyrvaya nasal pump during the course of this safety-focused trial.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 7 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Incidence of Adverse Events
Other outcome measures
Eye Dryness Score
Tear Film Break up Time
Trial Design
1Treatment groups
Experimental Treatment
Group I: Nasal PumpExperimental Treatment1 Intervention
Tyrvaya nasal pump with additional silicone lubricant
Find a Location
Who is running the clinical trial?
Oyster Point Pharma, Inc.Lead Sponsor
14 Previous Clinical Trials
2,003 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is the enrollment for this study currently available to prospective participants?
"As per clinicaltrials.gov, this specific trial is not currently open for enrollment. Its initial posting was on February 21st, 2024, with the most recent update on March 19th, 2024. Although recruitment has closed for this study, there are approximately 94 alternative trials actively seeking participants."
Answered by AI
Has the Nasal Pump been given clearance by the FDA?
"Our team at Power has assessed Nasal Pump's safety level as 3, based on the Phase 4 trial status which indicates its regulatory approval."
Answered by AI
Share this study with friends
Copy Link
Messenger